40
Participants
Start Date
February 28, 2011
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Hyaluronic Acid Filler
The dosage is individualized depending on the depth of the NLF. The goal is to achieve optimal correction of both NLF with single implantations of Belotero® Basic and Juvéderm® Ultra 3 respectively. Each subject will be injected with Belotero® Basic and Lidocaine containing Juvéderm® Ultra 3 according to a split-face design. The allocation of fillers to the side of the face will be randomized. The randomization method is block-wise with a ratio 1:1 to the groups Belotero® Basic left and Juvéderm® Ultra 3 right, Belotero® Basic right and Juvéderm® Ultra 3 left.
Praxisklinik Kaiserplatz, Frankfurt am Main
Lead Sponsor
Merz Pharmaceuticals GmbH
INDUSTRY